Describe The Structure Of The Ige Antibody Protein

Lab Reagents

Ige Antibody Laboratories manufactures the describe the structure of the ige antibody protein reagents distributed by Genprice. The Describe The Structure Of The Ige Antibody Protein reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact ige antibody. Other Describe products are available in stock. Specificity: Describe Category: The Group: Structure Of

Structure Of information

Brother of The Regulator of Imprinted Sites (BORIS) Antibody

20-abx141817
  • EUR 370.00
  • EUR 606.00
  • EUR 300.00
  • 100 ul
  • 200 ul
  • 50 ul

Cancer of the liver paired with normal of the liver, 51 cases (1.1mm), set 1

LVC1531 1
EUR 250
Description: Liver cancer tissue array, set 1, 51 cases, 153 cores, one normal paired with two tumor tissue cores from each patient with grading and TNM staging data.

Target of The Antiproliferative Antibody 1 (TAPA1) Antibody

20-abx130846
  • EUR 411.00
  • EUR 133.00
  • EUR 1149.00
  • EUR 565.00
  • EUR 314.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Target of The Antiproliferative Antibody 1 (TAPA1) Antibody

20-abx270047
  • EUR 467.00
  • EUR 537.00
  • EUR 272.00
  • EUR 815.00
  • EUR 356.00
  • 100 tests
  • 200 tests
  • 25 tests
  • 500 tests
  • 50 tests

Target Of The Antiproliferative Antibody 1 (TAPA1) Antibody

20-abx174717
  • EUR 815.00
  • EUR 425.00
  • 1 mg
  • 200 ug

ELISA kit for Human Fc?R ? (Receptor ? for the Fc Fragment of IgE)

E-EL-H1742 1 plate of 96 wells
EUR 534
Description: A sandwich ELISA kit for quantitative measurement of Human Fc?R ? (Receptor ? for the Fc Fragment of IgE) in samples from Serum, Plasma, Cell supernatant

Human Receptor II for the Fc Fragment of IgE (FcεR II) CLIA Kit

abx197638-96tests 96 tests
EUR 825

Human Target Of The Antiproliferative Antibody 1 (TAPA1) Protein

20-abx168684
  • EUR 481.00
  • EUR 230.00
  • EUR 1330.00
  • EUR 551.00
  • EUR 342.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Recombinant Target Of The Antiproliferative Antibody 1 (TAPA1)

4-RPB160Hu01
  • EUR 333.86
  • EUR 192.00
  • EUR 976.96
  • EUR 392.32
  • EUR 684.64
  • EUR 286.00
  • EUR 2292.40
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Target Of The Antiproliferative Antibody 1 expressed in: E.coli

Cancer of the lung, 102 cases (1.5mm)

LUC1021 1
EUR 250
Description: Lung cancer tissue array, 102 cases of normal/benign (5 cases) and cancer (97 cases with grading and TNM staging data.) tissues

Cancer of the lung, 228 cases (1.1mm)

LUC2281 1
EUR 460
Description: Lung cancer tissue array containing 8 cases of normal/benign conditions and 220 cases of cancers with grading and TNM staging data.

Cancer of the liver, 102 cases (1.5mm)

LVC1021 1
EUR 250
Description: Liver cancer tissue array, 102 cases of normal/benign (5 cases) and cancer (97 cases) tissues with grading and TNM staging data

Cancer of the liver, 228 cases (1.1mm)

LVC2281 1
EUR 460
Description: Liver cancer tissue array containing 8 cases of normal/benign conditions and 220 cases of cancers with grading and TNM staging data.

Cancer of the esophagus, 102 cases (1.5mm)

ESC1021 1
EUR 250
Description: Esophagus cancer tissue array, 102 cases of normal/benign (5 cases) and cancer (97 cases with grading and TNM staging data) tissues.

Cancer of the esophagus, 228 cases (1.1mm)

ESC2281 1
EUR 460
Description: Esophagus cancer tissue array containing 8 cases of normal/benign conditions and 220 cases of cancers with grading and TNM staging data.

Cancer of the cervix, 102 cases (1.5mm)

CXC1021 1
EUR 250
Description: Cervix cancer tissue array, 102 cases of normal/benign (5 cases) and cancer (97 cases with grading and TNM staging data) tissues.

Cancer of the cervix, 228 cases (1.1mm)

CXC2281 1
EUR 460
Description: Cervical cancer tissue array containing 8 cases of normal/benign conditions and 220 cases of cancers with grading and TNM staging data.